Deals Rumor Mill: AstraZeneca, ICBC, Johnson & Johnson
AstraZeneca may be looking to increase its stake in its diabetes joint venture with Bristol-Myers Squibb Co. following on the heels of Bristol's announcement Thursday it would no longer conduct research...To view the full article, register now.
Already a subscriber? Click here to view full article